Multi-omics Study Identifies Major Sources of Variability in iPSC-Derived Neurons for Disease Modeling
Researchers systematically mapped the sources of molecular variability in induced pluripotent stem cell (iPSC)-derived neurons across six omics layers for three rare genetic disorders. They found that clonal variability was comparable in magnitude to differences between patients, with neuronal differentiation state and nutrient-driven metabolic activity as dominant contributors. The findings provide concrete guidelines for study design and data correction that could improve biomarker discovery and the reliability of iPSC-based disease modeling.
A preprint study posted to bioRxiv profiled iPSC-derived neurons from patients with three rare genetic disorders—Myotonic Dystrophy Type 1, CDKL5-related disorder, and N-acetylneuraminic acid synthase deficiency—using genomics, epigenomics, transcriptomics, proteomics, metabolomics, and lipidomics. The central finding is that clonal variability, meaning differences between cell lines derived from the same patient, was roughly as large as differences between distinct patients, a result with significant implications for experimental design. Neuronal differentiation state and nutrient-driven metabolic activity emerged as the dominant sources of variation across all omics layers examined. Stochastic differences in DNA methylation patterns established during the reprogramming process were identified as a partial explanation for clonal divergence. By statistically modeling and correcting for these confounding sources of variation, the researchers were able to improve detection of disease-associated molecular signatures that would otherwise be obscured. The study offers practical recommendations for minimizing variability in iPSC experiments, which could strengthen the field's ability to use these models for robust biomarker discovery and therapeutic development.
What's missing
As a preprint, this work has not yet undergone peer review, and findings should be interpreted with appropriate caution. The study is limited to three specific rare genetic disorders, and it is unclear how generalizable the variability patterns and correction strategies are to other diseases or cell types. The sample sizes per disorder are not specified in the abstract, which limits assessment of statistical power. Additionally, the study does not address whether the proposed correction methods perform consistently across different iPSC reprogramming protocols or laboratory environments.
What different sources said
- bioRxivCenter
Dissecting the sources of variation in neuronally differentiated iPSC lines through multi-omics analysis
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.